Cargando…

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is a highly lethal malignancy due to a lack of early detection approaches coupled with poor outcomes for patients with clinically advanced disease. Cancer-testis (CT) or cancer-germline genes encode antigens known to generate spontaneous anti-tumor immunity in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wa, Barger, Carter J, Link, Petra A, Mhawech-Fauceglia, Paulette, Miller, Austin, Akers, Stacey N, Odunsi, Kunle, Karpf, Adam R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622579/ https://www.ncbi.nlm.nih.gov/pubmed/26098711 http://dx.doi.org/10.1080/15592294.2015.1062206

Ejemplares similares

Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
por: Zhang, Wa, et al.
Publicado: (2020)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro
por: Odunsi, Kunle, et al.
Publicado: (2012)

Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration
por: Koop, Anja, et al.
Publicado: (2013)

Microarray Analysis Reveals Distinct Gene Expression Profiles Among Different Tumor Histology, Stage and Disease Outcomes in Endometrial Adenocarcinoma
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2010)

Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer
por: Daudi, Sayeema, et al.
Publicado: (2014)

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
por: Barger, Carter J., et al.
Publicado: (2015)

Expression of the POTE gene family in human ovarian cancer
por: Barger, Carter J, et al.
Publicado: (2018)

Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
por: Liao, Jianqun, et al.
Publicado: (2014)

MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy
por: Srivastava, Pragya, et al.
Publicado: (2016)

Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
por: Barger, Carter J, et al.
Publicado: (2021)

Lower extremity pain as initial presentation of cervical cancer()
por: Dandapani, Savita V., et al.
Publicado: (2013)

The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers
por: Vermehren-Schmaedick, Anke, et al.
Publicado: (2020)

Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation
por: Kim, Robert, et al.
Publicado: (2013)

The Cancer/Testis Antigen CT45A1 Promotes Transcription of Oncogenic Sulfatase-2 Gene in Breast Cancer Cells and Is Sensible Targets for Cancer Therapy
por: Yang, Ping, et al.
Publicado: (2023)

Association between global DNA hypomethylation in leukocytes and risk of breast cancer
por: Choi, Ji-Yeob, et al.
Publicado: (2009)

Paratubal serous borderline tumor in an 85 years old woman: A case report
por: Mehawej, Jordy, et al.
Publicado: (2020)

Overexpression of DNA damage-induced 45 α gene contributes to esophageal squamous cell cancer by promoter hypomethylation
por: Wang, Bao xiang, et al.
Publicado: (2012)

Cancer/testis antigen 45 is expressed in a nuclear speckles-like pattern in human tumor cell lines
por: Heidebrecht, HJ, et al.
Publicado: (2009)

YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer
por: Suzuki, Izumi, et al.
Publicado: (2021)

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer
por: Xiong, Shigang, et al.
Publicado: (2019)

PS45. SLC1A2 Promoter is Hypomethylated in Bipolar Disorder with Comorbid Addiction
por: Veldic, Marin, et al.
Publicado: (2016)

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor
por: Kim, Grace, et al.
Publicado: (2015)

Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants
por: Malham, Melissa Bou, et al.
Publicado: (2023)

A novel cancer/testis antigen KP-OVA-52 identified by SEREX in human ovarian cancer is regulated by DNA methylation
por: KIM, KANG-MI, et al.
Publicado: (2012)

Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

Gadd45g Is Essential for Primary Sex Determination, Male Fertility and Testis Development
por: Johnen, Heiko, et al.
Publicado: (2013)

The soluble cytoplasmic tail of CD45 (ct‐CD45) in human plasma contributes to keep T cells in a quiescent state
por: Puck, Alexander, et al.
Publicado: (2016)

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
por: Liu, Cassie, et al.
Publicado: (2021)

Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer
por: Barger, Carter J, et al.
Publicado: (2019)

Hypomethylation‐activated cancer‐testis gene SPANXC promotes cell metastasis in lung adenocarcinoma
por: Wang, Xuewei, et al.
Publicado: (2019)

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
por: Wysham, Weiya Z., et al.
Publicado: (2012)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer
por: Samanta, Soma, et al.
Publicado: (2017)

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series
por: Matsuo, Koji, et al.
Publicado: (2015)

The sentinel node in breast cancer: an update: Monday 3 October 2005, 08:45–10:45
por: Collins, Conor D
Publicado: (2005)

Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer
por: Batman, Samantha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u22jile5q9cm73ft0o5049keit